Pump up the volume

24th May 2024

Published in PharmaTimes magazine - June 2024
Decentralised trials, meaningful diversity in and the patient voice

The success of clinical trials hinges on clear research objectives and quality data.

But underlying the ideal of clinical research lies a diverse cohort of patients, whose lived experiences are increasingly recognised by the medical community as integral to drug discovery and long-term outcomes.

Decentralised clinical trial (DCTs) design and patient insight boards are two key methods that, when used in tandem, can help ensure clinical data retains the nuance, humanity, and relevance to all stakeholders engaged in clinical research.

If decentralised trials provide a breadth of raw patient information, patient insight boards bring the depth of first-hand knowledge of lived experiences into clear focus, providing the basis for true empathetic technical solutions.

Check out the rest of the feature here

PharmaTimes Magazine

Article published in June 2024 Magazine

Tags